Stat Transcription Factors in Mammary Gland Development and Tumorigenesis

Journal of Mammary Gland Biology and Neoplasia

Volumn 6, Issue 1, 2001, Pages 115-127

  Watson, Christine J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apoptosis; Breast cancer; Involution; Mammary gland; Stat

Indexed keywords

DNA BINDING PROTEIN; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; STAT1 PROTEIN, MOUSE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE; STAT4 PROTEIN; STAT4 PROTEIN, HUMAN; STAT4 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL; BREAST; EXPERIMENTAL NEOPLASM; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BREAST; DNA-BINDING PROTEINS; FEMALE; HUMANS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0035230599     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009524817155     Document Type: Article

References (57)

1. J. E. Darnell, Jr. (1997). Stats and gene regulation. Science 277: 1630-1635.
2. X. S. Hou, M. B. Melnick, and N. Perrimon (1996). Marelle acts downstream of the Drosophila HOP/Jak kinase and encodes a protein similar to the mammalian STATs. Cell 84:411-419.
3. T. Kawata, A. Schevchenko, M. Fukuzawa, K. A. Jermyn, N. F. Totty, N. V. Zhukovskaya, A. E. Sterling, M. Mann, and J. G. Williams (1997). SH2 signaling in a lower eukaryote: A Stat protein that regulates stalk cell differentiation in Dictyostelium. Cell 89:909-916.
4. J. E. Durbin, R. Hackenmiller, M. C. Simon, and D. E. Levy (1996). Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450.
5. M. A. Merez, J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber (1996). Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442.
6. M. H. Kaplan, Y-L Sun, T. Hoey, and M. J. Grusby (1996). Impaired IL-12 responses and development of Th2 cells in Stat4 deficient mice. Nature 382:174-177.
7. K. Shimoda, J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-633.
8. K. Takeda, K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and S. Akira (1997). Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 94:3801-3804.
9. S. Akira (2000). Roles of Stat3 defined by tissue-specific gene targeting. Oncogene 19:2607-2611.
10. R. S. Chapman, P. C. Lourenco, E. Tonner, D. J. Flint, S. Selbert, K. Takeda, S. Akira, A. R. Clarke, and C. J. Watson (1999). Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev. 13:2604-2616.
11. X. Liu, G. W. Robinson, K. U. Wagner, L. Garret, A. Wynshaw-Boris, and L. Henninghausen (1997). Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11:179-186.
12. S. Teglund, C. McKay, E. Schuetz, J. M. van Deursen, D. Stravopodis, D. Wang, M. Brown, S. Bodner, G. Grosveld, and J. N. Ihle (1998). Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841-850.
13. G. B. Udy, R. P. Towers, R. G. Snell, R. J. Wilkins, S. H. Park, P. A. Ram, R. J. Waxman, and H. W. Davey (1997). Requirement of Stat5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 94:7239-7244.
14. R. Starr, T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton (1997). A family of cytokine-inducible inhibitors of signaling. Nature 387:917-921.
15. K. Shuai (2000). Modulation of Stat signaling by Stat-interacting proteins. Oncogene 19:2638-2644.
16. B. G. Neel and N. K. Tonks (1997). Protein tyrosine phosphatases in signal transduction. Current Opin. Cell Biol. 9:193-204.
17. J. A. C. Philp, T. G. Burdon, and C. J. Watson (1996). Differential activation of Stats 3 and 5 during mammary gland development. FEBS Lett. 396:77-80.
18. X. Liu, G. W. Robinson, and L. Henninghausen (1996). Activation of Stat5a and Stat5b by tyrosine phosphorylation in tightly linked to mammary gland differentiation. Mol. Endocrinol. 10:1496-1506.
19. T. G. Burdon, J. Demmer, A. J. Clark, and C. J. Watson (1994). The mammary factor MPBF is a prolactin-induced transcriptional regulator which binds to Stat factor recognition sites. FEBS Lett. 350:177-182.
20. J. Demmer, T. G. Burdon, J. Djiane, C. J. Watson, and A. J. Clarke (1995). The proximal milk protein binding factor binding site is required for the prolactin responsiveness of the sheep β-lactoglobulin promoter in Chinese hamster ovary cells. Mol. Cell. Endocrinol. 107:113-121.
21. M. Schmitt-Ney, W. Doppler, R. K. Ball, and B. Groner (1991). Beta-casein gene promoter activity is regulated by the hormone mediated relief of transcriptional repression and a mammary-specific nuclear factor. Mol. Cell. Biol. 11:3745-3755.
22. C. J. Ormandy, A. Camus, J. Barra, D. Damotte, B. Lucas, H. Buteau, M. Edery, N. Brousse, C. Babinet, N. Binart, and P. A. Kelly (1997). Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11:167-178.
23. T. G. Burdon, K. A. Maitland, A. J. Clark, R. Wallace, and C. J. Watson (1994). Regulation of the sheep β-lactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-γ activation site-related element. Mol. Endocrinol. 8:152-1536.
24. S. Li and J. M. Rosen (1995). Nuclear factor I and mammary gland factor (Stat5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol. Cell. Biol. 15:2063-2070.
25. S. John, U. Vinkemeier, E. Soldaini, J. E. Darnell Jr., and W. J. Leonard (1999). The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 19:1910-1918.
26. J. Rossant and A. McMahon (1999)."Cre"-ating mouse mutants: A meeting review on conditional mouse genetics. Genes Dev. 13:142-145.
27. H. Akaishi, K. Takeda, T. Kaisho, R. Shineha, S. Satomi, J. Takeda, and S. Akira (1998). Defective IL-2-mediated IL-2 receptor α chain expression in Stat3 deficient T lymphocytes. Int. Immunol. 10:1747-1751.
28. S. Selbert, D. J. Bently, D. W. Melton, D. Rannie, P. Lourenco, C. J. Watson, and A. R. Clarke (1998). Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgenic Res. 7:387-396.
29. K. E. Gordon, B. Binas, R. S. Chapman, K. M. Kurian, R. W. E. Clarkson, A. J. Clark, E. B. Lane, and C. J. Watson (2000). A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland. Breast Cancer Res. 2:222-235.
30. C. H. Shen and J. Stavnezer (1998). Interaction of Stat6 and NF-αB: Direct association and synergistic activation of interleukin-4-induced transcription. Mol. Cell. Biol. 18:3395-3404.
31. R. W. E. Clarkson, J. L. Heeley, R. S. Chapman, F. Aillet, R. T. Hay, A. H. Wyllie, and C. J. Watson (2000). NF-κB inhibits apoptosis in murine mammary epithelia. J. Biol. Chem. 275:12737-12742.
32. A. V. Kazansky, B. Raught, S. M. Lindsey, Y. Wang, and J. M. Rosen (1995). Regulation of mammary gland factor/Stat5a during mammary gland development. Mol. Endocrinol. 9:1598-1609.
33. C. Lee, F. Piazza, S. Brutsaert, J. Valens, I. Strehlow, M. Jarosinski, C. Saris, and C. Schindler (1999). Characterization of the Stat5 protease. J. Biol.Chem. 274:26767-26775.
34. T. van den Bruggen, E. Caldenhoven, D. Kanters, P. Coffer, J. A. Raaijmakers, J. W. Lammers, and L. Koenderman (1995). Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha. Blood 85:1442-1448.
35. E. Caldenhoven, M. Buitenhuis, T. B. van Dijk, J. A. Raaijmakers, J. W. Lammers, L. Koenderman, and R. P. de Groot (1999). Lineage specific activation of Stat3 by interferon-gamma in human neutrophils. J. Leukoc. Biol. 65:391-396.
36. N. Carlesso, D. A. Frank, and J. D. Griffin (1996). Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (Stat) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183:811-820.
37. V. Gouilleux-Gruart, F. Gouilleux, C. Desaint, J. F. Claisse, J. C. Capiod, J. Delobel, R. Weber-Nordt, I. Dussanter-Fourt, F. Dreyfus, B. Groner, and L. Prin (1996) Stat-related transcription factors are constitutively activated in peripheral blood cells from acute leukaemia patients. Blood 87:1692-1697.
38. T. S. Mignone, J. X. Lin, A. Cereseto, J. C. Mulloy, J. J. Os, G. Franchini, and W. J. Leonard (1995). Constitutively activated Jak-Stat pathway in T cells transformed with HTLV-1. Science 269:79-81.
39. C. Arnould, C. Philippe, V. Bourdon, M. J. Grigoire, R. Berger, and P. Jonveaux (1999). The signal transducer and activator of transcription Stat5b gene is a new partner of retinoic acid receptor α in acute promyelocytic-like leukaemia. Human Mol. Genet. 8:1741-1749.
40. J. Rubin-Grandis, S. D. Drenning, Q. Zeng, S. C. Watkins, M. F. Melhem, S. Endo, D. E. Johnson, L. Huang, Y. He, and J. D. Kim (1998). Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. 97:4227-4232.
41. T. Bowman, R. Garcia, J. Turkson, and R. Jove (2000). Stats in oncogenesis. Oncogene 19:2474-2488.
42. A. Fernandes, A. W. Hamburger, and B. I Gerwin (1999). ErbB-2 kinase is required for constitutive Stat3 activation in malignant human lung epithelial cells. Int. J. Cancer 83:564-570.
43. G. Niu, R. Heller, R. Catlett-Falcone, D. Coppola, M. Jaroszeski, W. Dalton, R. Jove, and H. Yu. (1999). Gene therapy with dominant negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 59:5059-5063.
44. R. Garcia, C. L. Yu, A. Hudnall, R. Catlett, K. L. Nelson, T. Smithgall, D. J. Fujita, S. P. Ethier, and R. Jove (1997). Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 8:1267-1276.
45. W. H. Sun, C. Pabon, Y. Alsayed, P. P. Huang, S. Jandeska, S. Uddin, L. C. Platanias, and S. T. Rosen (1998). Interferon-α resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood 91:570-576.
46. C. J. Watson and W. R. Miller (1995). Elevated levels of members of the Stat family of transcription factors in breast carcinoma nuclear extracts. Brit. J. Cancer 71:840-844.
47. C. I. Sartor, M. L. Dziubinski, C. L. Yu, R. Jove, and S. P. Ethier (1997). Role of epidermal growth factor receptor and Stat3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res. 57:978-987.
48. N. N. Danial, J. A. Losman, T. Lu, N. Yip, K. Krishnan, J. Krolewski, S. P. Goff, J. Y. Wang, and P. B. Rothman (1998). Direct interaction of Jak1 and v-AbI is required for v-Abl-induced activation of STATs and proliferation. Mol. Cell. Biol. 18:6759-6804.
49. K. Shuai, J. Liao, and M. M. Song (1996). Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol. Cell. Biol. 16:4932-4941.
50. N. Aoki and T. Matsuda (2000). A cytosolic protein tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated Stat5a and Stat5b. J. Biol. Chem. (in press).
51. J. F. Bromberg, M. H. Wrzeszcynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell, Jr. (1999). Stat3 as an oncogene. Cell 98:295-303.
52. M. Onishi, T. Nosaka, K. Misawa, A. L. Mui, D. German, M. McMahon, A. Miyajima, and T. Kitamura (1998). Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol. Cell. Biol. 18:3871-3879.
53. Y. Morita, T. Naka, Y. Kawazoe, M. Fujimoto, M. Narazaki, R. Nakagawa, H. Fukuyama, S. Nagata, and T. Kishimoto (2000). Signal transducers and activators of transcription (Stat)-induced Stat inhibitor-1 (Ssi-1)/suppressors of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 97:5405-5410.
54. D. Metcalf, C. J. Greenhalgh, E. Viney, T. A. Willson, R. Starr, N. A. Nicola, D. J. Hilton and W. S. Alexander (2000). Gigantism in mice lacking suppressor of cytokine signaling-2. Nature 405:1069-1073.
55. R. G. Collum, S. Brutsaert, G. Lee, and C. Schindler (2000). A Stat3-interacting protein (StIP1) regulated cytokine signal transduction. Proc. Natl. Acad. Sci. U.S.A. 97:10120-10125.
56. D. H. Kaplan, V. Shankaran, A. S. Dinge, E. Stockert, M. Aguet, L. J. Old, and R. D. Schreiber (1998). Demonstration of an interferon γ-dependent tumor surveillance system in immuno-competent mice. 95:7556-7561.
57. C. K. Lee, E. Smith, R. Gimeno, R. Gertner, and D. E. Levy (2000). Stat1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma. J. Immunol. 164:1286-1292.